I like the old stuff better than the new stuff? Subjective experiences of new psychoactive substances.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  The International journal on drug policy

• Publication date

  2017-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.drugpo.2016.11.004PMID 27939599
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Motivations for new psychoactive substance use among regular psychostimulant users in Australia.

  2017cited by this paper
• New psychoactive substance use among regular psychostimulant users in Australia, 2010-2015.

  2016cited by this paper
• Exploring the Attractiveness of New Psychoactive Substances (NPS) among Experienced Drug Users

  2015cited by this paper
• Self-reported prevalence of dependence of MDMA compared to cocaine, mephedrone and ketamine among a sample of recreational poly-drug users.

  2015cited by this paper
• Dimethyltryptamine (DMT): Prevalence, user characteristics and abuse liability in a large global sample

  2014influential reference
• The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample

  2014cited by this paper
• Do Novel Psychoactive Substances Displace Established Club Drugs, Supplement Them or Act as Drugs of Initiation? The relationship between Mephedrone, Ecstasy and Cocaine

  2013cited by this paper
• Substitutional potential of mephedrone: an analysis of the subjective effects

  2013cited by this paper
• Cognitive and subjective effects of mephedrone and factors influencing use of a 'new legal high'.

  2012cited by this paper
• Self-Reported Prevalence of Osteoporosis in Australia

  2012cited by this paper
• Instability of the ecstasy market and a new kid on the block: mephedrone

  2011influential reference
• Mephedrone, new kid for the chop?

  2011cited by this paper
• A web-based survey on mephedrone.

  2011cited by this paper
• Mephedrone: use, subjective effects and health risks.

  2011cited by this paper
• Social, policy, and public health perspectives on new psychoactive substances.

  2011cited by this paper
• A Preference for Mephedrone: Drug Markets, Drugs of Choice, and the Emerging “Legal High” Scene

  2011cited by this paper
• Queensland Trends in Ecstasy and Related Drug Markets 2012: Findings from the Ecstasy and Related Drugs Reporting System (EDRS): Australian drug trends series no. 108

  2011cited by this paper
• Tweaking, bombing, dabbing and stockpiling: the emergence of mephedrone and the perversity of prohibition

  2010cited by this paper
• Mass‐information: mephedrone, myths, and the new generation of legal highs

  2010cited by this paper
• Mephedrone: still available and twice the price.

  2010cited by this paper
• Tasmanian Trends in Ecstasy and Related Drug Markets 2006: Findings from the Ecstasy and Related Drugs Reporting System (EDRS)

  2007cited by this paper
• Self-report among injecting drug users: a review.

  1998cited by this paper

• Tusi but not 2C: A Miami‐Dade medical examiner case series highlighting the variable drug composition in colored powder paraphernalia

  2025cites this paper
• Vulnerability factors for mephedrone-induced conditioned place preference in rats—the impact of sex differences, social-conditioning and stress

  2021cites this paper
• International snapshot of new psychoactive substance use: Case study of eight countries over the 2019/2020 new year period.

  2021cites this paper
• Suitability of infrared spectroscopy for drug checking in harm reduction centres.

  2020cites this paper
• The Clinical Toxicology of 4-Bromo-2,5-dimethoxyphenethylamine (2C-B): The Severity of Poisoning After Exposure to Low to Moderate and High Doses.

  2020cites this paper
• New psychoactive substances in Australia: patterns and characteristics of use, adverse effects, and interventions to reduce harm.

  2020cites this paper
• Interpol review of controlled substances 2016–2019☆

  2020cites this paper
• Abuse potential and toxicity of the synthetic cathinones (i.e., "Bath salts").

  2020cites this paper
• Acute Effects of 2C-E in Humans: An Observational Study

  2020cites this paper
• Sex, Drugs, and Bitcoin: How Much Illegal Activity Is Financed through Cryptocurrencies?

  2019cites this paper
• Synthetic Cathinone Use Among Polysubstance Users: Indirect Indicator of Indiscriminate Drug Taking or Preferred Drug of Abuse?

  2019cites this paper
• In silico toxicity as a tool for harm reduction: A study of new psychoactive amphetamines and cathinones in the context of criminal science.

  2019cites this paper
• “Go ask Alice, when she’s 10-feet tall”: Psychosocial correlates to lifetime LSD use among a national sample of US adults

  2019cites this paper
• Sex differences in α-pyrrolidinopentiophenone (α-PVP)-induced taste avoidance, place preference, hyperthermia and locomotor activity in rats.

  2019cites this paper
• New psychoactive substances: challenges for drug surveillance, control, and public health responses.

  2019cites this paper
• An observational study on the sub-acute effects of mephedrone on mood, cognition, sleep and physical problems in regular mephedrone users

  2018cites this paper
• Essays on Regulating Pain and Pleasure

  2018cites this paper
• Synthetic Cathinones: Neurotoxic Health Hazards and Potential for Abuse

  2018cites this paper
• Diffusion of New Psychoactive Substances: understanding population motives, harms and intervention needs

  2018cites this paper
• New psychoactive substances: Purchasing and supply patterns in Australia

  2017cites this paper
• New drugs, new directions? Research priorities for new psychoactive substances and human enhancement drugs.

  2017cites this paper
• Examination of Synthetic Cannabinoid and Cathinone Use among a Drug-Using Offender Sample, 2013–2015

  2017cites this paper
• Motivations for new psychoactive substance use among regular psychostimulant users in Australia.

  2017influential citation